Amanote Research

Amanote Research

    RegisterSign In

99mTc-Labelled Stealth® Liposomal Doxorubicin (Caelyx®) in Glioblastomas and Metastatic Brain Tumours

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6600093
Full Text
Open PDF
Abstract

Available in full text

Categories
Cancer ResearchOncology
Date

February 1, 2002

Authors
P LavermanO C BoermanG StormW J G Oyen
Publisher

Springer Science and Business Media LLC


Related search

Stealth Station® Treon®Plus Neuronavigation System in Surgery of Intracranial Meningiomas

Ukrainian Neurosurgical Journal
2010English

Efficacy and Safety of Non-Pegylated Liposomal Doxorubicin in Metastatic Breast Cancer Therapy

OnCOReview
Oncology
2017English

Access to Liposomal Generic Formulations: Beyond AmBisome and Doxil/Caelyx

GaBI Journal
Drug GuidesPharmacy
2013English

Multicenter Experience of Nonpegylated Liposomal Doxorubicin Use in the Management of Metastatic Breast Cancer

Clinical Breast Cancer
Cancer ResearchOncology
2014English

Nexplanon®: What Implanon® Did Next

Journal of Family Planning and Reproductive Health Care
2010English

Tumor Imaging With 99mTc-Labelled Antibody Fragments.

RADIOISOTOPES
1984English

Neuroprotective Effect of Pycnogenol® Following Traumatic Brain Injury

Experimental Neurology
Developmental NeuroscienceNeurology
2013English

Reolysin® Enters Clinical Trial for Patients With Metastatic Colorectal Cancer

Immunotherapy
OncologyAllergyImmunology
2009English

Turnitin®

Active Learning in Higher Education
Education
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy